Search results
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 4 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 6 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Theralase(R) Successfully Destroys Lung Cancer
Morningstar· 3 hours agocancers, bacteria and viruses, is pleased to announce that it's lead compound, RuvidarTM, combined with transferrin to form the compound Rutherrin®, has been proven effective ...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 6 days agoPatients with an incurable form of lung cancer could lead normal lives by taking a daily pill that...
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 6 days agoPfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 3 days agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 6 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 17 hours agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Study reveals role of neutrophil lipid transfer in lung cancer transition
Medical Xpress· 17 hours agoPhenotypic plasticity is a cancer hallmark, and lung adeno-to-squamous transition (AST) triggered by...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 2 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
